Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | -7.89% | -28.57% |
05:45pm | Valneva SE Appoints Daniele Guyot-Caparros as Board of Directors | CI |
Jun. 24 | Valneva's Chikungunya Vaccine Receives Health Canada's Approval | MT |
Sales 2024 * | 190M 203M | Sales 2025 * | 234M 249M | Capitalization | 469M 501M |
---|---|---|---|---|---|
Net income 2024 * | 6M 6.41M | Net income 2025 * | -29M -30.98M | EV / Sales 2024 * | 2.88 x |
Net Debt 2024 * | 77.76M 83.06M | Net Debt 2025 * | 94.16M 101M | EV / Sales 2025 * | 2.41 x |
P/E ratio 2024 * |
30.6
x | P/E ratio 2025 * |
-43.5
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
0.3% | Free-Float | 83.51% |
Latest transcript on Valneva SE Pref.
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 13-05-09 | |
Peter Buhler
DFI | Director of Finance/CFO | 54 | 21-07-28 |
Vincent Dequenne
COO | Chief Operating Officer | - | 21-07-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kathrin Jansen
BRD | Director/Board Member | - | 23-06-20 |
James Sulat
BRD | Director/Board Member | 73 | 13-03-06 |
Jim Connolly
BRD | Director/Board Member | 59 | 22-06-23 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.26% | 52.73B | |
+37.49% | 39B | |
-8.68% | 38.52B | |
+28.05% | 30.38B | |
-12.26% | 26.39B | |
+10.59% | 26.08B | |
+45.18% | 14.15B | |
+32.45% | 12.6B | |
-6.60% | 11.51B |
- Stock Market
- Equities
- VLA Stock
- VLAP Stock